Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

RADIOGARDASE (PRUSSIAN BLUE)

FERRIC HEXACYANOFERRATE(II)

Standard Dose
500MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview RADIOGARDASE (PRUSSIAN BLUE) is listed in Drugs@FDA under application 021626 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient FERRIC HEXACYANOFERRATE(II) Form and strength CAPSULE;ORAL - 500MG Sponsor HEYL CHEMISCH Submission history Latest submission status date: 2014-08-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview RADIOGARDASE (PRUSSIAN BLUE) is listed in Drugs@FDA under application 021626 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient FERRIC HEXACYANOFERRATE(II) Form and strength CAPSULE;ORAL - 500MG Sponsor HEYL CHEMISCH Submission history Latest submission status date: 2014-08-20 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Prescription
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
RADIOGARDASE (PRUSSIAN BLUE) (FERRIC HEXACYANOFERRATE(II)) | Drug Monograph | MedicHelpline